ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

RFA On Breast Tumor Factors Patients Survival

June 20, 1980

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion.

December 2, 2005

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009